Viewing Study NCT07172204

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:12 PM
Ignite Modification Date: 2026-04-04 @ 5:37 AM
Study NCT ID: NCT07172204
Status: RECRUITING
Last Update Posted: 2025-11-28
First Post: 2025-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
Sponsor: First Affiliated Hospital of Zhejiang University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intensive Chemotherapy Unfit View
None Newly Diagnosed Acute Myeloid Leukemia (AML) View
None Age ≥60 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute Myeloid Leukemia View
None Venetoclax View
None alternating View
None Homoharringtonine View
None Cladribine View
None age 60 and older View
None intensive chemotherapy unfit View
None newly diagnosed View